These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 15234332)
1. Neuropathology provides clues to the pathophysiology of Gaucher disease. Wong K; Sidransky E; Verma A; Mixon T; Sandberg GD; Wakefield LK; Morrison A; Lwin A; Colegial C; Allman JM; Schiffmann R Mol Genet Metab; 2004 Jul; 82(3):192-207. PubMed ID: 15234332 [TBL] [Abstract][Full Text] [Related]
2. Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism. Furderer ML; Hertz E; Lopez GJ; Sidransky E Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628652 [TBL] [Abstract][Full Text] [Related]
3. Tuft-shaped astrocytes in Lewy body disease. Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789 [TBL] [Abstract][Full Text] [Related]
4. Gaucher disease: complexity in a "simple" disorder. Sidransky E Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415 [TBL] [Abstract][Full Text] [Related]
5. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Farfel-Becker T; Vitner EB; Pressey SN; Eilam R; Cooper JD; Futerman AH Hum Mol Genet; 2011 Apr; 20(7):1375-86. PubMed ID: 21252206 [TBL] [Abstract][Full Text] [Related]
6. Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Pelled D; Trajkovic-Bodennec S; Lloyd-Evans E; Sidransky E; Schiffmann R; Futerman AH Neurobiol Dis; 2005 Feb; 18(1):83-8. PubMed ID: 15649698 [TBL] [Abstract][Full Text] [Related]
7. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Kersaitis C; Halliday GM; Kril JJ Acta Neuropathol; 2004 Dec; 108(6):515-23. PubMed ID: 15368070 [TBL] [Abstract][Full Text] [Related]
8. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558 [TBL] [Abstract][Full Text] [Related]
9. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Vitner EB; Dekel H; Zigdon H; Shachar T; Farfel-Becker T; Eilam R; Karlsson S; Futerman AH Hum Mol Genet; 2010 Sep; 19(18):3583-90. PubMed ID: 20616152 [TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Parkkinen L; Kauppinen T; Pirttilä T; Autere JM; Alafuzoff I Ann Neurol; 2005 Jan; 57(1):82-91. PubMed ID: 15562510 [TBL] [Abstract][Full Text] [Related]
11. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Braak H; Sastre M; Del Tredici K Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
14. No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Farfel-Becker T; Vitner E; Dekel H; Leshem N; Enquist IB; Karlsson S; Futerman AH Hum Mol Genet; 2009 Apr; 18(8):1482-8. PubMed ID: 19193629 [TBL] [Abstract][Full Text] [Related]
15. Global gene expression in a type 2 Gaucher disease brain. Myerowitz R; Mizukami H; Richardson KL; Finn LS; Tifft CJ; Proia RL Mol Genet Metab; 2004 Dec; 83(4):288-96. PubMed ID: 15589115 [TBL] [Abstract][Full Text] [Related]
16. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses. Finn LS; Zhang M; Chen SH; Scott CR Am J Med Genet; 2000 Mar; 91(3):222-6. PubMed ID: 10756347 [TBL] [Abstract][Full Text] [Related]
17. Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature. Kraoua I; Stirnemann J; Ribeiro MJ; Rouaud T; Verin M; Annic A; Rose C; Defebvre L; Réménieras L; Schüpbach M; Belmatoug N; Vidailhet M; Sedel F Mov Disord; 2009 Jul; 24(10):1524-30. PubMed ID: 19513999 [TBL] [Abstract][Full Text] [Related]
18. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations. Piran S; Roberts A; Patterson MA; Amato D Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665 [TBL] [Abstract][Full Text] [Related]
19. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Schell H; Hasegawa T; Neumann M; Kahle PJ Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424 [TBL] [Abstract][Full Text] [Related]
20. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Diaz-Corrales FJ; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N Neuroscience; 2005; 133(1):117-35. PubMed ID: 15893636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]